Susquehanna Downgrades RXO to Negative, Lowers Price Target to $14
Portfolio Pulse from richadhand@benzinga.com
Susquehanna analyst Bascome Majors has downgraded RXO (NYSE:RXO) from Neutral to Negative and lowered the price target from $19 to $14.
August 31, 2023 | 10:33 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RXO has been downgraded from Neutral to Negative by Susquehanna, with a lowered price target from $19 to $14.
The downgrade from Neutral to Negative by Susquehanna, along with a lowered price target, indicates a bearish outlook for RXO. This could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100